Deal slippage diagnosis is the systematic analysis of why deals that should close this quarter keep pushing to next quarter—costing you 20-40% of your forecasted revenue. It’s the process of identifying the root causes behind deals that perpetually move from “closing this month” to “probably next month” in your pipeline. Picture this: It’s Friday afternoon.
Picture this: A founder at $800K ARR watches competitors land $2M enterprise deals with major health systems while they’re still pitching rule-based decision trees. Clinical decision support AI implementation is the strategic capability that separates B2B healthcare companies that scale from those that stall — it’s the difference between being a vendor and becoming critical
The founder-led sales to sales team transition happens when you hit the painful ceiling where closing deals yourself is killing your product velocity—typically between $500K-$1M ARR for B2B SaaS companies. You know you’ve hit it when you’re spending 60% of your time in sales calls instead of building, and your engineering team is shipping at
Most solo founders approach CRM setup backwards, starting with software features instead of revenue architecture. A proper CRM setup for solo founder operations means building a system that captures every customer interaction, automates follow-ups, and generates intelligence about your sales pipeline—all while requiring minimal maintenance as you scale from zero to $3M ARR. Picture this: